Christoph Correll; Christoph U Correll
Christoph Correll; Christoph U Correll
Professor of Psychiatry and Molecular Medicine, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead, NY USA; Professor of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany; Investigator, Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research Manhasset, NY, USA
Dirección de correo verificada de northwell.edu - Página principal
Título
Citado por
Citado por
Año
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
M De Hert, CU Correll, J Bobes, M Cetkovich-Bakmas, DAN Cohen, I Asai, ...
World psychiatry 10 (1), 52, 2011
20542011
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents
CU Correll, P Manu, V Olshanskiy, B Napolitano, JM Kane, AK Malhotra
Jama 302 (16), 1765-1773, 2009
10672009
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents
CU Correll, P Manu, V Olshanskiy, B Napolitano, JM Kane, AK Malhotra
Jama 302 (16), 1765-1773, 2009
10672009
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
M De Hert, J Detraux, R Van Winkel, W Yu, CU Correll
Nature Reviews Endocrinology 8 (2), 114-126, 2012
9222012
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies
CU Correll, S Leucht, JM Kane
American Journal of psychiatry 161 (3), 414-425, 2004
8502004
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
M De Hert, DAN Cohen, J Bobes, M Cetkovich-Bakmas, S Leucht, ...
World psychiatry 10 (2), 138, 2011
8302011
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review …
D Vancampfort, B Stubbs, AJ Mitchell, M De Hert, M Wampers, PB Ward, ...
World Psychiatry 14 (3), 339-347, 2015
7782015
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients …
CU Correll, M Solmi, N Veronese, B Bortolato, S Rosson, P Santonastaso, ...
World Psychiatry 16 (2), 163-180, 2017
7632017
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials
S Leucht, TRE Barnes, W Kissling, RR Engel, C Correll, JM Kane
American Journal of Psychiatry 160 (7), 1209-1222, 2003
6672003
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
CU Correll, J Detraux, J De Lepeleire, M De Hert
World psychiatry 14 (2), 119-136, 2015
6312015
Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program
JM Kane, DG Robinson, NR Schooler, KT Mueser, DL Penn, ...
American Journal of Psychiatry 173 (4), 362-372, 2016
5742016
How mental health care should change as a consequence of the COVID-19 pandemic
C Moreno, T Wykes, S Galderisi, M Nordentoft, N Crossley, N Jones, ...
The Lancet Psychiatry, 2020
5072020
Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents
CU Correll, HE Carlson
Journal of the American Academy of Child & Adolescent Psychiatry 45 (7), 771-791, 2006
4752006
The schizophrenia prodrome revisited: a neurodevelopmental perspective
BA Cornblatt, T Lencz, CW Smith, CU Correll, AM Auther, E Nakayama
Schizophrenia bulletin 29 (4), 633-651, 2003
4752003
Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials
CU Correll, C Rummel-Kluge, C Corves, JM Kane, S Leucht
Schizophrenia bulletin 35 (2), 443-457, 2009
4622009
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
4552017
National trends in the mental health care of children, adolescents, and adults by office-based physicians
M Olfson, C Blanco, S Wang, G Laje, CU Correll
JAMA psychiatry 71 (1), 81-90, 2014
4452014
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis
D Vancampfort, CU Correll, B Galling, M Probst, M De Hert, PB Ward, ...
World Psychiatry 15 (2), 166-174, 2016
4442016
Tardive dyskinesia and new antipsychotics
CU Correll, EM Schenk
Current opinion in psychiatry 21 (2), 151-156, 2008
4322008
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
J Firth, N Siddiqi, A Koyanagi, D Siskind, S Rosenbaum, C Galletly, ...
The Lancet Psychiatry 6 (8), 675-712, 2019
4102019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20